<DOC>
	<DOC>NCT03010696</DOC>
	<brief_summary>The purpose of this study is to investigate the differences of gut Microbiome/Metabolite between ESRD patients and healthy subjects. Two hundred and twenty three hemodialysis patients and 70 healthy subjects are recruited, and a cross-sectional study is performed.</brief_summary>
	<brief_title>The Correlation Between Gut Microbiome/Metabolite and End Stage Renal Disease (ESRD)</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>For Healthy Subjects Age over 18 years old Liver and kidney function is normal 18.5≤BMI≤29.9 Agree to sign the informed consent form Diagnosed as Metabolic syndrome Diagnosed as Cirrhosis Diagnosed as kidney disease Taking fermented food (live lactic acid bacteria drinks, cheese, yogurt, probiotic products, etc.) within 14 days before the study Taking antibiotics or antifungal drugs within 30 days before the study For ESRD patients Inclusion criteria: Age over 18 years old Patients who diagnosed as ESRD with hemodialysis Fixed hemodialysis cycle (average 3 times a week) Agree to sign the informed consent form Exclusion criteria: Taking antibiotics or antifungal drugs within 30 days before the study Taking fermented food (live lactic acid bacteria drinks, cheese, yogurt, probiotic products, etc.) within 14 days before the study Reasercher are not sure whether the subjects are willing or able to complete the study Subject participated in other research projects within two months before the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Kidney Failure, Chronic</keyword>
	<keyword>Uremic toxins</keyword>
	<keyword>Gastrointestinal Microbiome</keyword>
	<keyword>Metabolomics</keyword>
</DOC>